Volume 7, Issue 9 , Pages 966-971, September 2009
Stratifying Risk for Celiac Disease in a Large At-Risk United States Population by Using HLA Alleles
Background & Aims
Susceptibility to celiac disease (CD) is related to HLA-DQ2 and DQ8 alleles and the heterodimers they encode. The objective of this study was to stratify risk for CD on the basis of HLA-DQ genotype.
Methods
DNA from 10,191 subjects who are at risk for CD was analyzed for HLA-DQ haplotypes. Individuals with CD were identified as those who tested positive for anti-endomysial immunoglobulin A (EMA+) in an immunofluorescence assay.
Results
Samples homozygous for DQ2.5 (HLA-DQA1*05-DQB1*02) or DQ2.2/DQ2.5 (HLA-DQA1*05-DQB1*02 and HLA-DQA1*0201-DQB1*02) comprised 5.38% of the total; 28.28% of these were EMA+ (95% confidence interval [CI], 24.55–32.26). Of the samples that were DQ2.5 heterozygous (HLA-DQA1*05-DQB1*02); 9.09% were EMA+ (95% CI, 7.82–10.51). Among samples in which HLA-DQ8 (HLA-DQA1*03-DQB1*0302) was detected, 8.42% of homozygotes (95% CI, 3.71–15.92) and 2.11% of heterozygotes (95% CI, 1.43–3.00) were EMA+. Samples with DQ2.2/DQ8 or DQ2.5/DQ8 comprised 5.08% of the total, and 11.78% of these were EMA+ (95% CI, 9.13–14.87). HLA-DQ2 and HLA-DQ8 were absent in 4283 samples (42.03% of the total); 0.16% of these samples were EMA+ (95% CI, 0.07–0.34).
Conclusions
High-resolution, sequence-specific oligonucleotide probe typing with 35 DQA1-specific and 37 DQB1-specific probes of DNA from more than 10,000 subjects was used to stratify risk of CD in an at-risk U.S. population. DQ2 homozygosity (DQ2.5/DQ2.2+2.5) increased risk for CD, estimated by the rate of EMA positivity, compared with the entire sample population and other DQ genotypes. These data suggest a quantitative relationship between the type/proportion of DQ heterodimers and the risk of CD and identify potential immunotherapeutic targets.
To view this article's video abstract, go to the AGA's YouTube Channel.
Abbreviations used in this paper: CD, celiac disease, CI, confidence interval, EMA, anti-endomysial IgA antibody, GFD, gluten-free diet
Conflicts of interest The authors disclose the following: Michelle Pietzak has received research support, acts as a consultant for, and has received honoraria from the speaker's bureau of Prometheus Laboratories Inc. Timothy C. Schofield, Matthew J. McGinniss, and Robert M. Nakamura are employees of Prometheus Laboratories Inc.
Funding This manuscript was supported by an unrestricted grant from Prometheus Laboratories Inc. Editorial assistance and statistical analysis were provided by MDG Development Group. Prometheus Laboratories Inc provided financial support for this assistance.
PII: S1542-3565(09)00482-0
doi:10.1016/j.cgh.2009.05.028
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
-


Analysis of HLA and Non-HLA Alleles Can Identify Individuals at High Risk for Celiac Disease
, 18 May 2009
Volume 7, Issue 9 , Pages 966-971, September 2009


